Monitor Q2 2026 actual results due in August for the magnitude of the miss and any further commentary on market stabilization. The strong applicator business provides a partial offset, but the capital equipment disruption is a near-term headwind.
Price Chart
Executive Summary
SANUWAVE Health pre-announced Q2 2026 revenue guidance of $8.5-$9.5 million, below prior expectations, citing CMS reimbursement clawbacks causing wound care practice closures and a secondary market cannibalizing Ultramist system sales. Applicator volumes remain robust and on pace for a record quarter, but the capital equipment headwind is material.
Key Financial Metrics
Key Facts
- Q2 2026 revenue guidance lowered to $8.5-$9.5 million, below prior guidance provided on May 13, 2026
- CEO attributes disruption to widespread CMS reimbursement clawbacks for skin sub and allograft usage, driving wound care practice closures and a secondary market for used Ultramist systems
- Applicator (consumable) volumes remain robust, on pace for a record quarterly unit volume in Q2
Financial Impact
Revenue guidance reduced from prior undisclosed level to $8.5-$9.5 million for Q2 2026
Risk Factors
- Further deterioration in wound care practice viability and additional secondary market cannibalization
- Potential for additional guidance cuts if market conditions worsen
- Reliance on consumable revenue growth to offset capital equipment declines
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3312487 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 8-K | $4.65 $4.70 | ▼ −1.08% | ▲ +0.13% | $5.19 (−11.61%) |
Aug 6, 2026 11w ago | 8-K | $5.88 $4.74 | ▲ +19.39% | ▲ +19.79% | $5.19 (+11.73%) |
Aug 6, 2026 11w ago | Press Release | $5.88 $4.74 | ▲ +19.39% | ▲ +19.79% | $5.19 (+11.73%) |
Jul 30, 2026 12w ago | Press Release | $6.17 $5.88 | ▼ −4.70% | ▼ −8.21% | $5.19 (−15.88%) |
Jun 16, 2026 19w ago | 8-K | $8.51 $8.20 | ▲ +3.64% | ▲ +1.41% | $5.19 (+39.01%) |
Jun 16, 2026 19w ago | Press Release | $8.51 $8.20 | ▲ +3.64% | ▲ +1.41% | $5.19 (+39.01%) |
Jun 11, 2026 19w ago | Institutional Cluster | $14.69 $9.09 | ▼ −38.12% | ▼ −38.55% | $5.19 (−64.67%) |
May 12, 2026 23w ago | Press Release | $18.94 $16.69 | ▼ −11.88% | ▼ −10.72% | $5.19 (−72.60%) |
May 6, 2026 24w ago | Press Release | $16.65 $18.94 | ▲ +13.75% | ▲ +12.25% | $5.19 (−68.83%) |
Apr 16, 2026 27w ago | 8-K | $20.61 $18.70 | ▼ −9.27% | ▼ −9.82% | $5.19 (−74.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers